Artelo Biosciences, Inc. (NASDAQ:ARTL) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Closed: US$2M raised · US$4.4 a share · R.F. Lafferty & Co., Inc. Dealers: R.F. Lafferty & Co., Inc. (lead) | Oct 1, 2025 |
| Public offering of shares of common stock and pre-funded warrants Closed: US$3M raised · US$4.4 a share · R. F. Lafferty & Co., Inc. Dealers: R. F. Lafferty & Co., Inc. (lead) | Sep 5, 2025 |
| Private placement of shares of common stock (or pre-funded warrants) and warrants Announced: about US$9.47M · US$10.45 a share · three-year warrants to purchase 906,687 shares at $10.20 per share and three-year… · R. F. Lafferty & Co., Inc. Dealers: R. F. Lafferty & Co., Inc. Buyers: Bartosz Lipiński (lead investor) Use of proceeds: Launch a Solana (SOL)-centric digital asset treasury strategy and support ongoing business | Aug 4, 2025 |
| Private placement of shares of common stock, pre-funded warrants and accompanying warrants Announced: about US$1.43M · accompanying warrants to purchase 460,046 shares at $5.82 per share and 230,023 shares… Use of proceeds: Announce clinical data for ART26.12 and ART27.13 studies; $250,000 to buy SOL digital currency; balance for general corporate and working capital | Jun 26, 2025 |
| At-market convertible notes Closed: US$900,000 raised Use of proceeds: To fund company operations until additional financing is completed | May 13, 2025 |